OnCo
Start here·Rankings·All cancers

Cancers by number of approved products

JSON

Cancers ordered by how many products with status approved list them. Top 50 of 248 cancers with a value; ties are broken by name. 452 of 484 approved products name at least one cancer (93%).

#CancerApproved products
1Non-small-cell lung cancer91
2HR-positive / HER2-negative breast cancer62
3Colorectal cancer38
4Prostate cancer37
5Diffuse large B-cell lymphoma35
6Acute lymphoblastic leukaemia33
7Multiple myeloma33
8Acute myeloid leukaemia32
9Gastric & gastro-oesophageal junction cancer28
10Bladder & urothelial cancer25
11Ovarian cancer24
12Triple-negative breast cancer (TNBC)24
13Melanoma23
14Chronic lymphocytic leukaemia22
15Sarcomas (soft tissue, bone, GIST)22
16Pancreatic ductal adenocarcinoma20
17Renal cell carcinoma19
18Hepatocellular carcinoma18
19HER2-positive breast cancer18
20Hodgkin lymphoma18
21Head and neck squamous cell carcinoma16
22Cervical cancer15
23Small-cell lung cancer15
24Thyroid cancer13
25Advanced melanoma (unresectable stage III and stage IV)12
26Glioma & glioblastoma11
27EGFR-mutated non-small-cell lung cancer10
28HR-positive metastatic breast cancer after CDK4/6 inhibitors10
29Metastatic castration-resistant prostate cancer10
30Myeloproliferative neoplasms (PV, ET, myelofibrosis)10
31Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma)10
32Relapsed or refractory multiple myeloma10
33Endometrial cancer9
34Neuroendocrine tumours9
35Advanced hepatocellular carcinoma (BCLC C)8
36Biliary tract cancer (cholangiocarcinoma)8
37Chronic myeloid leukaemia (CML)8
38Extensive-stage small-cell lung cancer8
39Myelodysplastic syndromes / neoplasms (MDS)8
40Neuroblastoma (paediatric)8
41ALK-positive non-small-cell lung cancer7
42BRAF V600-mutant melanoma7
43Follicular lymphoma7
44Mesothelioma7
45MET exon 14 and MET-amplified non-small-cell lung cancer7
46Metastatic hormone-sensitive prostate cancer7
47Oesophageal cancer7
48Stage III melanoma (after surgery)7
49Basal cell carcinoma6
50Mantle cell lymphoma6

198 more cancers have a value below the top 50; the full list of cancers is at /cancers/.

How this is counted

Counts drug records with status approved and at least one approval record whose cancers field lists the cancer. A product approved in several cancers counts once for each. The context column counts trial records naming the cancer.

Coverage. 452 of 484 approved products name at least one cancer (93%). Rows with a value of zero are not listed. Nothing is weighted, imputed or averaged; the ordering is by the number shown, then by name.

Machine-readable copy: /rankings/cancers-by-approved-drugs/data.json. Registry: src/lib/rankings.ts.

Other rankings